Viridian Therapeutics
VRDN
#5299
Rank
NZ$1.84 B
Marketcap
$22.64
Share price
-0.44%
Change (1 day)
6.21%
Change (1 year)

EPS for Viridian Therapeutics (VRDN)

EPS in 2023 (TTM): -$7.94

According to Viridian Therapeutics's latest financial reports the company's current EPS (TTM) is -$8.17. In 2022 the company made an earnings per share (EPS) of -$6.76 an increase over its 2021 EPS that were of -$12.71.

EPS history for Viridian Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$7.9417.47%
2022-$6.76-46.83%
2021-$12.71-73.94%
2020-$48.7844.73%
2019-$33.7122.94%
2018-$27.42-27.33%
2017-$37.73-91.47%
2016-$442.20-19.17%
2015-$547.08-75.48%
2014-$2,231582.47%
2013-$326.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.66-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA